Shareholding disclosure

Johnson & Johnson

Declared position

4.25%

Threshold

Crossed upwards

Timeline

Published

11.04.2017

Transaction

05.04.2017

Voting rights breakdown

Voting rights acquired4.25%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAH4A000E7

Beneficial owner

Johnson & Johnson

Declared address

Johnson & Johnson, New Brunswick, New Jersey

Date of transfer of equity securitieson or around 10.04.17, no later than 18.04.17

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Johnson & Johnson

Molecular Partners AG11.04.2017TAH4A000E7

Disclosure summary

Johnson & Johnson disclosed a holding in Molecular Partners AG on the acquisition side, published by SIX Exchange Regulation on 11.04.2017, at 4.25% of voting rights. Notice category: Single shareholder.

Disclosed position

4.25%

Voting rights acquired

Voting rights acquired4.25%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Johnson & Johnson disclosed a holding in Molecular Partners AG, published on 11.04.2017.

Publication date11.04.2017

Transaction date05.04.2017

Issuing companyMolecular Partners AG

Beneficial ownerJohnson & Johnson

Declared addressJohnson & Johnson, New Brunswick, New Jersey

CategorySingle shareholder

Voting rights acquired4.25%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAH4A000E7

Conditions

Date of transfer of equity securitieson or around 10.04.17, no later than 18.04.17

Source: SIX Exchange Regulation · Publication date: 11.04.2017

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open